Browsing: vaccines

Five years after the COVID-19 pandemic, a revolutionary medical technology faces growing skepticism.

BioVaxys Technology Corp. will present its latest developments at the Emerging Growth Conference.

Two new studies explore how innovations in the R&D ecosystem—from AI to smarter trial designs—could overcome challenges and accelerate the development of life-saving health technologies, particularly for neglected diseases and emerging threats.

BioVaxys Technology Corp. will present at the Emerging Growth Conference on January 16, 2025, offering investors and analysts a real-time interactive session with the company’s leadership.